14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $40.39 $44.07 Friday, 3rd May 2024 IONS stock ended at $41.97. This is 2.60% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.36% from a day low at $41.93 to a day high of $43.76.
90 days $40.39 $51.98
52 weeks $34.79 $54.44

Historical Ionis Pharmaceuticals prices

Date Open High Low Close Volume
Jul 19, 2023 $42.00 $42.46 $41.46 $42.03 840 872
Jul 18, 2023 $42.19 $42.72 $41.96 $42.08 1 017 475
Jul 17, 2023 $42.77 $43.88 $42.13 $42.20 1 582 354
Jul 14, 2023 $42.82 $43.00 $42.24 $42.48 641 135
Jul 13, 2023 $42.53 $43.44 $42.10 $42.66 1 149 405
Jul 12, 2023 $42.09 $42.77 $41.50 $42.52 1 180 199
Jul 11, 2023 $41.74 $42.15 $41.43 $42.10 563 101
Jul 10, 2023 $41.81 $42.37 $41.44 $41.78 1 080 833
Jul 07, 2023 $41.73 $42.59 $41.68 $41.78 845 988
Jul 06, 2023 $42.12 $42.12 $41.63 $41.76 902 080
Jul 05, 2023 $41.11 $42.21 $41.02 $42.19 607 126
Jul 03, 2023 $41.14 $41.61 $40.95 $41.08 419 587
Jun 30, 2023 $41.47 $41.60 $40.84 $41.03 741 186
Jun 29, 2023 $40.85 $41.72 $40.64 $41.11 1 252 020
Jun 28, 2023 $39.23 $40.87 $38.95 $40.85 1 336 081
Jun 27, 2023 $39.13 $39.64 $38.88 $39.36 849 890
Jun 26, 2023 $39.66 $39.71 $39.01 $39.10 892 216
Jun 23, 2023 $40.98 $40.91 $39.58 $39.64 1 204 016
Jun 22, 2023 $41.26 $42.19 $40.94 $41.20 1 316 631
Jun 21, 2023 $40.99 $41.43 $40.49 $41.27 1 350 118
Jun 20, 2023 $40.88 $41.86 $40.56 $41.07 1 152 032
Jun 16, 2023 $41.91 $41.98 $40.96 $41.02 1 071 686
Jun 15, 2023 $40.81 $41.78 $40.60 $41.69 1 222 281
Jun 14, 2023 $41.96 $41.99 $40.62 $40.82 1 193 322
Jun 13, 2023 $41.70 $42.22 $41.47 $41.89 1 314 732
Click to get the best stock tips daily for free!

About Ionis Pharmaceuticals

Ionis Pharmaceuticals Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various... IONS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT